Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
about
Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndromeIntratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndromeBronchoalveolar lavage.Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models.Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants.Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn ratsInhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygenPrediction of chronic neonatal lung disease in very low birthweight neonates using clinical and radiological variablesChronic lung disease in the preterm infant. Lessons learned from animal modelsbeta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia.Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity.Choriodecidual infection downregulates angiogenesis and morphogenesis pathways in fetal lungs from Macaca nemestrinaGene expression profile of endotoxin-stimulated leukocytes of the term new born: control of cytokine gene expression by interleukin-10.Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.Proteases and oxidants in experimental pulmonary inflammatory injury.Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.Role of serine proteases in the regulation of interleukin-877 during the development of bronchopulmonary dysplasia in preterm ventilated infantsBlood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestationBronchopulmonary dysplasia: then and nowBronchopulmonary dysplasia early changes leading to long-term consequences.Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia.Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice.Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infantsRepeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenationIL-1beta disrupts postnatal lung morphogenesis in the mouseInhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growthPulmonary inflammation and bronchopulmonary dysplasia.Prostanoids in bronchoalveolar lavage fluid do not predict outcome in congenital diaphragmatic hernia patientsInflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates.Mechanisms of bronchopulmonary dysplasia.Factors affecting surfactant responsiveness.Transcriptional control of cytokine release from monocytes of the newborn: effects of endogenous and exogenous interleukin-10 versus dexamethasone.Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactionsErythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats.Effect of ductus ligation on cardiopulmonary function in premature baboonsIntracellular and extracellular serpins modulate lung disease.Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.Pathophysiology of neonatal lung injury.Oxygen and oxidative stress in bronchopulmonary dysplasia.
P2860
Q24234404-9A085671-872E-4E62-B77E-AAC280811918Q24241764-653D4AE8-2585-431E-BA22-FDC8D795CEE8Q24515404-F2A03981-284B-4D7A-B218-98B41E5505DFQ24812352-AF9342F0-9F2F-413B-A7C4-55E683FB9295Q31027804-F5BDF32D-72C3-491D-B692-E92E853BE8D3Q33378441-EE92A01D-794A-4D43-B2C5-51B600C26F18Q33693056-B8A0F2A2-2509-40D9-9C56-E60A8E3B3900Q33706474-714E89B8-0699-40E7-AB4E-A5B6CBF7AE14Q33756577-A53104C3-9B1B-4F1D-881C-020B87C2444BQ34026324-223715C2-E224-481F-AAA4-76CC208250D5Q34064422-A519DF82-0D7E-44B3-93D4-225F60996B56Q34442340-AEF0D491-C7CA-4918-891D-544B1E25C2CEQ34551636-3EEA0CFB-C6C1-4193-80FF-BFBE90A89266Q34556193-B3E8C236-CE93-41AA-A95C-5B02FEAC8158Q34608359-C30DE403-49CC-4ED7-88C0-226C291946D8Q34609321-8BCEF3B5-7C43-4089-B571-A7AED6CCEDADQ34634652-F7125D56-7F74-4613-B04D-7614836B2E00Q34876759-AC77DB8F-D069-4BC4-A25A-E5B1AC23B19AQ35066440-1789DC9F-1DE0-4EEE-817B-B892E24A4328Q35077309-D4ACCD88-E1ED-4524-836E-7A5E72632617Q35194438-DB2A1A65-271C-4968-B120-B0E355818879Q35219764-39B57BBC-DC64-4679-AA65-1E583B50609EQ35286042-0C62B98B-EB03-4918-BB3E-6E7D3AF25954Q35534305-500F5CBF-9864-4476-AD70-2CE8118E253BQ35855262-36DF378A-892A-4B12-8650-F5A2A841B532Q35871662-E2BAB701-A60D-4A08-9152-2E057D30F672Q36178195-D3D30F6F-C90F-46A9-8292-9AAF78DB671AQ36453829-D3DA8470-6CC0-4EE8-9712-CCB1C19A3A8FQ36628177-0A5D96AA-4BA4-4DDE-B077-80D44827A156Q36763758-46F44E01-5792-4F53-89D5-BFBEF6FB937EQ36864667-8E926D6A-4198-4B8D-BBC2-88D60C2CD579Q36928292-E77739AB-1BBF-4610-91B1-BA8B57C72625Q36966024-21103654-1E72-4D46-8729-70BB9A51E7B1Q36994626-5CC747E0-EE68-4C16-8D93-D6ECB51B4528Q37223145-A9EC4CC3-FCD3-4CFE-8B95-A0F299C67A7DQ37282749-6024E5C5-34B5-4AC9-AE9F-9AF710A7FD6AQ37341652-92B8D07D-3372-430D-9DC2-57698728A22FQ37656267-CC9540BB-2FA8-4138-AA17-0D4FABEA3D33Q37726200-1ECFDD02-D469-4B6E-8752-DCBA7036E010Q37784210-FC1FDEB8-9D65-493E-86A8-870CC9364E5E
P2860
Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Elastase and alpha 1-proteinas ...... of bronchopulmonary dysplasia.
@en
type
label
Elastase and alpha 1-proteinas ...... of bronchopulmonary dysplasia.
@en
prefLabel
Elastase and alpha 1-proteinas ...... of bronchopulmonary dysplasia.
@en
P2093
P2860
P356
P1476
Elastase and alpha 1-proteinas ...... of bronchopulmonary dysplasia.
@en
P2093
C G Cochrane
D K Edwards
T A Merritt
P2860
P304
P356
10.1172/JCI111015
P407
P577
1983-08-01T00:00:00Z